BIOMAT Database Logo BIOMAT Database Logo

[Visualization, diagnostic capability and safety of iopamidol, a nonionic contrast medium in cardiovascular angiography]. 1984

H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi

UI MeSH Term Description Entries
D007479 Iopamidol A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. B-15,000,B-15000,Gastromiro,Iopamidol, (+-)-Isomer,Iopamidol, (R)-Isomer,Iopamidol, Sodium Salt, (S)-Isomer,Iopamiro,Isovue,Isovue 370,Jopamidol,Niopam,SQ 13,396,Solutrast,Solutrast 370,Solutrast Gastro,B 15,000,B 15000,B15,000,B15000
D007483 Iothalamic Acid A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts. Iotalamic Acid,Methalamic Acid,Angio-Conray,Conray 420,Iodothalamate,Iothalamate,Iothalamic Acid, Calcium (2:1) Salt,Iothalamic Acid, Monosilver (1+) Salt,Iothalamic Acid, Monosodium Salt,Iothalamic Acid, Monosodium Salt, Dimer,Lopamidol,Sodium Iothalamate,Acid, Iotalamic,Acid, Iothalamic,Acid, Methalamic,Angio Conray,AngioConray,Iothalamate, Sodium
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006349 Heart Valve Diseases Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). Heart Valvular Disease,Valvular Heart Diseases,Disease, Heart Valvular,Heart Disease, Valvular,Heart Valve Disease,Heart Valvular Diseases,Valve Disease, Heart,Valvular Disease, Heart,Valvular Heart Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Iopamidol, a new nonionic contrast medium in peripheral angiography.
January 1982, Cardiovascular and interventional radiology,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
[Experiences with the nonionic contrast medium iopamidol in cerebral angiography].
February 1985, Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Safety of the nonionic contrast medium omnipaque in coronary angiography.
January 1989, Cardiovascular and interventional radiology,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Cardiovascular effects induced by the injection of a new nonionic contrast medium (Iopamidol): experimental study in dogs.
January 1979, Investigative radiology,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
[Abdominal angiography with a non-ionic contrast medium, iopamidol].
January 1984, Nihon geka hokan. Archiv fur japanische Chirurgie,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
January 1982, Neuroradiology,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
February 1985, Journal of the American College of Cardiology,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
[Ventriculography with a new water-soluble nonionic contrast medium - Iopamidol (author's transl)].
December 1981, La Radiologia medica,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
[Intravenous urography with a nonionic low osmolality contrast medium (iopamidol) in elderly patients].
December 1988, Hinyokika kiyo. Acta urologica Japonica,
H Manabe, and T Kozuka, and K Kimura, and H Koyanagi, and S Suzuki, and S Handa, and H Akiyama, and K Hiramatsu, and H Yamaguchi, and S Nakanishi
Visualization of breast lymphatic pathways with an indirect computed tomography lymphography using a nonionic monometric contrast medium iopamidol: preliminary results.
February 2003, Investigative radiology,
Copied contents to your clipboard!